Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

The biggest names in diabetes tech gathered last weekend for the American Diabetes Association’s 86th Scientific Sessions ...

First participant enrolled in randomized control trial designed to demonstrate safety and efficacy of Insulet’s fully closed-loop automated insulin delivery system versus standard therapy Unique ...

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod ® 5 App for iPhone is now compatible with the ...

Findings from the STRIVE study indicated improved glycaemic control with Omnipod 6 compared to Omnipod 5.

Diabetes management software company Glooko will add its first two continuous glucose monitor and pump integrations into its offering: Dexcom's G4 CGM and Insulet's OmniPod Insulin Management System.

STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across age groups and diabetes types EVOLUTION 3 feasibility study demonstrates improved time in range using ...